Iterum Therapeutics Plc (ITRM) Tops Q3 EPS by 58c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q3 EPS of ($0.30), $0.58 better than the analyst estimate of ($0.88).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Movano (MOVE) Misses Q2 EPS by 195c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c